Thrivent Financial For Lutherans Bio Xcel Therapeutics, Inc. Transaction History

Thrivent Financial For Lutherans

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $46,400 - $110,200	20,000 Added 100.0%	40,000 $118,000
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $24,900 - $118,500	10,000 Added 100.0%	20,000 $50,000
Q2 2023 Aug 14, 2023	BUY	$6.39 - $28.58 $63,900 - $285,800	10,000 New	10,000 $64,000
Q2 2021 Aug 19, 2021	SELL	$29.06 - $38.83 $601,629 - $803,897	-20,703 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $104,314 - $172,611	-2,672 Reduced 11.43%	20,703 $893,000
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $992,502 - $1.32 Million	23,375 New	23,375 $1.08 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.